TickerFactsScreenerDevelopers

Processa Pharmaceuticals, Inc. (PCSA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $2.79M2012: $1.02M2013: $186.9K2014: $21.2K2015: $2.1K2016: $1.07M2017: $2.85M2018: $1.74M2019: $691.5K2020: $15.42M2021: $16.50M2022: $6.50M2023: $4.71M2024: $1.19M2025: $5.54M$5.54M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$5.54M+364.8%
2024$1.19M-74.7%
2023$4.71M-27.6%
2022$6.50M-60.6%
2021$16.50M+7.0%
2020$15.42M+2129.3%
2019$691.5K-60.3%
2018$1.74M-38.9%
2017$2.85M+165.6%
2016$1.07M+51186.8%
2015$2.1K-90.2%
2014$21.2K-88.6%
2013$186.9K-81.7%
2012$1.02M-63.5%
2011$2.79M—